Annual Operating Expenses
$33.33 M
+$10.06 M+43.22%
01 July 2024
Summary:
BriaCell Therapeutics annual total operating expenses is currently $33.33 million, with the most recent change of +$10.06 million (+43.22%) on 01 July 2024. During the last 3 years, it has risen by +$26.36 million (+378.04%). BCTX annual operating expenses is now at all-time high.BCTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$5.77 M
-$3.46 M-37.51%
01 July 2024
Summary:
BriaCell Therapeutics quarterly total operating expenses is currently $5.77 million, with the most recent change of -$3.46 million (-37.51%) on 01 July 2024. Over the past year, it has dropped by -$2.73 million (-32.17%). BCTX quarterly operating expenses is now -41.32% below its all-time high of $9.83 million, reached on 31 January 2024.BCTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCTX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.2% | -32.2% |
| 3 y3 years | +378.0% | +152.4% |
| 5 y5 years | +558.0% | +391.3% |
BCTX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +378.0% | -41.3% | +152.4% |
| 5 y | 5 years | at high | +751.1% | -41.3% | +2934.2% |
| alltime | all time | at high | >+9999.0% | -41.3% | >+9999.0% |
BriaCell Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | $33.33 M(+43.2%) | $5.77 M(-37.5%) |
| Apr 2024 | - | $9.23 M(-6.1%) |
| Jan 2024 | - | $9.83 M(+15.6%) |
| Oct 2023 | - | $8.50 M(+10.3%) |
| July 2023 | $23.27 M(+52.2%) | $7.71 M(+35.7%) |
| Apr 2023 | - | $5.68 M(+26.5%) |
| Jan 2023 | - | $4.49 M(-17.0%) |
| Oct 2022 | - | $5.40 M(+3.2%) |
| July 2022 | $15.29 M(+119.2%) | $5.23 M(+26.9%) |
| Apr 2022 | - | $4.12 M(+13.2%) |
| Jan 2022 | - | $3.64 M(+59.5%) |
| Oct 2021 | - | $2.28 M(+43.2%) |
| July 2021 | $6.97 M(+78.0%) | $1.60 M(-66.8%) |
| Apr 2021 | - | $4.81 M(+2428.5%) |
| Jan 2021 | - | $190.10 K(-50.0%) |
| Oct 2020 | - | $380.40 K(-59.3%) |
| July 2020 | $3.92 M(-22.7%) | $933.90 K(+86.3%) |
| Apr 2020 | - | $501.40 K(-64.7%) |
| Jan 2020 | - | $1.42 M(+21.1%) |
| Oct 2019 | - | $1.17 M(-31.4%) |
| July 2019 | $5.07 M(+32.6%) | $1.71 M(+53.8%) |
| Apr 2019 | - | $1.11 M(-18.3%) |
| Jan 2019 | - | $1.36 M(+38.9%) |
| Oct 2018 | - | $980.10 K(-32.0%) |
| July 2018 | $3.82 M(+47.9%) | $1.44 M(+29.9%) |
| Apr 2018 | - | $1.11 M(+39.1%) |
| Jan 2018 | - | $797.80 K(+58.6%) |
| Oct 2017 | - | $503.00 K(-53.4%) |
| July 2017 | $2.58 M(+54.9%) | $1.08 M(+25.5%) |
| Apr 2017 | - | $859.50 K(+154.2%) |
| Jan 2017 | - | $338.10 K(+4.0%) |
| Oct 2016 | - | $325.00 K(+58.1%) |
| July 2016 | $1.67 M(-38.9%) | $205.60 K(-24.6%) |
| Apr 2016 | - | $272.50 K(-64.9%) |
| Jan 2016 | - | $775.30 K(+148.1%) |
| Oct 2015 | - | $312.50 K(+138.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2015 | $2.73 M(+523.7%) | $131.20 K(-66.0%) |
| Apr 2015 | - | $386.20 K(-81.1%) |
| Jan 2015 | - | $2.04 M(+3607.5%) |
| Oct 2014 | - | $55.00 K(-68.6%) |
| July 2014 | $437.30 K(+3.1%) | $175.40 K(+75.6%) |
| Apr 2014 | - | $99.90 K(+20.2%) |
| Jan 2014 | - | $83.10 K(+2.8%) |
| Oct 2013 | - | $80.80 K(-12.5%) |
| July 2013 | $424.30 K(-23.1%) | $92.30 K(-22.4%) |
| Apr 2013 | - | $118.90 K(+9.2%) |
| Jan 2013 | - | $108.90 K(+2.3%) |
| Oct 2012 | - | $106.40 K(-17.8%) |
| July 2012 | $551.80 K(-47.6%) | $129.50 K(+3.0%) |
| Apr 2012 | - | $125.70 K(-11.3%) |
| Jan 2012 | - | $141.70 K(-5.4%) |
| Oct 2011 | - | $149.80 K(-70.4%) |
| July 2011 | $1.05 M(+224.5%) | $505.60 K(+114.9%) |
| Apr 2011 | - | $235.30 K(+27.2%) |
| Jan 2011 | - | $185.00 K(+71.6%) |
| Oct 2010 | - | $107.80 K(+161.7%) |
| July 2010 | $324.60 K(+38.8%) | $41.20 K(-75.3%) |
| Apr 2010 | - | $166.80 K(+221.4%) |
| Jan 2010 | - | $51.90 K(-8.9%) |
| Oct 2009 | - | $57.00 K(-59.4%) |
| July 2009 | $233.90 K(+105.0%) | $140.40 K(+1477.5%) |
| Apr 2009 | - | $8900.00(-73.9%) |
| Jan 2009 | - | $34.10 K(-34.7%) |
| Oct 2008 | - | $52.20 K(-7.9%) |
| July 2008 | $114.10 K(-11.6%) | $56.70 K(+100.4%) |
| Apr 2008 | - | $28.30 K(+45.1%) |
| Jan 2008 | - | $19.50 K(+89.3%) |
| Oct 2007 | - | $10.30 K(-73.9%) |
| July 2007 | $129.10 K(+1401.2%) | $39.40 K(+203.1%) |
| Apr 2007 | - | $13.00 K(-71.0%) |
| Jan 2007 | - | $44.90 K(+57.5%) |
| Oct 2006 | - | $28.50 K |
| July 2006 | $8600.00 | - |
FAQ
- What is BriaCell Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual operating expenses year-on-year change?
- What is BriaCell Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly operating expenses year-on-year change?
What is BriaCell Therapeutics annual total operating expenses?
The current annual operating expenses of BCTX is $33.33 M
What is the all time high annual operating expenses for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual total operating expenses is $33.33 M
What is BriaCell Therapeutics annual operating expenses year-on-year change?
Over the past year, BCTX annual total operating expenses has changed by +$10.06 M (+43.22%)
What is BriaCell Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of BCTX is $5.77 M
What is the all time high quarterly operating expenses for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly total operating expenses is $9.83 M
What is BriaCell Therapeutics quarterly operating expenses year-on-year change?
Over the past year, BCTX quarterly total operating expenses has changed by -$2.73 M (-32.17%)